Cargando…
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma
BACKGROUND AND PURPOSE: This study aimed to assess the role of T1 mapping and oxygen-enhanced MRI in patients undergoing radical dose radiotherapy for HPV positive oropharyngeal cancer, which has not yet been examined in an OE-MRI study. MATERIALS AND METHODS: Variable Flip Angle T1 maps were acquir...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841018/ https://www.ncbi.nlm.nih.gov/pubmed/36655119 http://dx.doi.org/10.1016/j.ctro.2022.100563 |
_version_ | 1784869740050644992 |
---|---|
author | Bluemke, Emma Bertrand, Ambre Chu, Kwun-Ye Syed, Nigar Murchison, Andrew G. Cooke, Rosie Greenhalgh, Tessa Burns, Brian Craig, Martin Taylor, Nia Shah, Ketan Gleeson, Fergus Bulte, Daniel |
author_facet | Bluemke, Emma Bertrand, Ambre Chu, Kwun-Ye Syed, Nigar Murchison, Andrew G. Cooke, Rosie Greenhalgh, Tessa Burns, Brian Craig, Martin Taylor, Nia Shah, Ketan Gleeson, Fergus Bulte, Daniel |
author_sort | Bluemke, Emma |
collection | PubMed |
description | BACKGROUND AND PURPOSE: This study aimed to assess the role of T1 mapping and oxygen-enhanced MRI in patients undergoing radical dose radiotherapy for HPV positive oropharyngeal cancer, which has not yet been examined in an OE-MRI study. MATERIALS AND METHODS: Variable Flip Angle T1 maps were acquired on a 3T MRI scanner while patients (n = 12) breathed air and/or 100 % oxygen, before and after fraction 10 of the planned 30 fractions of chemoradiotherapy (‘visit 1’ and ‘visit 2’, respectively). The analysis aimed to assess to what extent (1) native R1 relates to patient outcome; (2) OE-MRI response relates to patient outcome; (3) changes in mean R1 before and after radiotherapy related to clinical outcome in patients with oropharyngeal squamous cell carcinoma. RESULTS: Due to the radiotherapy being largely successful, the sample sizes of non-responder groups were small, and therefore it was not possible to properly assess the predictive nature of OE-MRI. The tumour R1 increased in some patients while decreasing in others, in a pattern that was overall consistent with the underlying OE-MRI theory and previously reported tumour OE-MRI responses. In addition, we discuss some practical challenges faced when integrating this technique into a clinical trial, with the aim that sharing this is helpful to researchers planning to use OE-MRI in future clinical studies. CONCLUSION: Altogether, these results suggest that further clinical OE-MRI studies to assess hypoxia and radiotherapy response are worth pursuing, and that there is important work to be done to improve the robustness of the OE-MRI technique in human applications in order for it to be useful as a widespread clinical technique. |
format | Online Article Text |
id | pubmed-9841018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98410182023-01-17 Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma Bluemke, Emma Bertrand, Ambre Chu, Kwun-Ye Syed, Nigar Murchison, Andrew G. Cooke, Rosie Greenhalgh, Tessa Burns, Brian Craig, Martin Taylor, Nia Shah, Ketan Gleeson, Fergus Bulte, Daniel Clin Transl Radiat Oncol Article BACKGROUND AND PURPOSE: This study aimed to assess the role of T1 mapping and oxygen-enhanced MRI in patients undergoing radical dose radiotherapy for HPV positive oropharyngeal cancer, which has not yet been examined in an OE-MRI study. MATERIALS AND METHODS: Variable Flip Angle T1 maps were acquired on a 3T MRI scanner while patients (n = 12) breathed air and/or 100 % oxygen, before and after fraction 10 of the planned 30 fractions of chemoradiotherapy (‘visit 1’ and ‘visit 2’, respectively). The analysis aimed to assess to what extent (1) native R1 relates to patient outcome; (2) OE-MRI response relates to patient outcome; (3) changes in mean R1 before and after radiotherapy related to clinical outcome in patients with oropharyngeal squamous cell carcinoma. RESULTS: Due to the radiotherapy being largely successful, the sample sizes of non-responder groups were small, and therefore it was not possible to properly assess the predictive nature of OE-MRI. The tumour R1 increased in some patients while decreasing in others, in a pattern that was overall consistent with the underlying OE-MRI theory and previously reported tumour OE-MRI responses. In addition, we discuss some practical challenges faced when integrating this technique into a clinical trial, with the aim that sharing this is helpful to researchers planning to use OE-MRI in future clinical studies. CONCLUSION: Altogether, these results suggest that further clinical OE-MRI studies to assess hypoxia and radiotherapy response are worth pursuing, and that there is important work to be done to improve the robustness of the OE-MRI technique in human applications in order for it to be useful as a widespread clinical technique. Elsevier 2022-12-17 /pmc/articles/PMC9841018/ /pubmed/36655119 http://dx.doi.org/10.1016/j.ctro.2022.100563 Text en © 2022 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Bluemke, Emma Bertrand, Ambre Chu, Kwun-Ye Syed, Nigar Murchison, Andrew G. Cooke, Rosie Greenhalgh, Tessa Burns, Brian Craig, Martin Taylor, Nia Shah, Ketan Gleeson, Fergus Bulte, Daniel Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title | Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title_full | Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title_fullStr | Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title_full_unstemmed | Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title_short | Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
title_sort | oxygen-enhanced mri and radiotherapy in patients with oropharyngeal squamous cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841018/ https://www.ncbi.nlm.nih.gov/pubmed/36655119 http://dx.doi.org/10.1016/j.ctro.2022.100563 |
work_keys_str_mv | AT bluemkeemma oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT bertrandambre oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT chukwunye oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT syednigar oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT murchisonandrewg oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT cookerosie oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT greenhalghtessa oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT burnsbrian oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT craigmartin oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT taylornia oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT shahketan oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT gleesonfergus oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma AT bultedaniel oxygenenhancedmriandradiotherapyinpatientswithoropharyngealsquamouscellcarcinoma |